Merck is set to lead pharmaceutical licensing deals in 2018
MedImmune and Abpro enter into a collaborative agreement for a novel bispecific antibody
AstraZeneca launches integrated genomics approach to transform drug discovery and development
AstraZeneca and Moderna Therapeutics link up to develop immuno-oncology mRNA therapeutics
Wacker Biotech grants MedImmune licence to use Esetec technology to manufacture antibody fragment
AstraZeneca signs third cancer deal in seven days
Medimmune partners with the University of Sheffield to innovate cell factory technology
New industry partnership with Pfizer will boost cancer research
Can new discoveries prevent an antibiotic Armageddon?
MedImmune enters research collaboration with Manchester University
COMBACTE-MAGNET project aims to stimulate antibiotic development in Europe
MedImmune to acquire Definiens for US$150m
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania join forces to tackle influenza and antibiotic-resistant bacteria
Making best use of big data
MedImmune and Immunocore in multi-million pound deal to develop new cancer drugs
